共 50 条
Multivessel versus culprit lesion only percutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis
被引:65
作者:
de Waha, Suzanne
[1
,2
]
Jobs, Alexander
[1
,2
]
Eitel, Ingo
[1
,2
]
Poess, Janine
[1
,2
]
Stiermaier, Thomas
[1
,2
]
Meyer-Saraei, Roza
[1
,2
]
Fuernau, Georg
[1
,2
]
Zeymer, Uwe
[3
]
Desch, Steffen
[1
,2
]
Thiele, Holger
[1
,2
,4
]
机构:
[1] Univ Hosp Schleswig Holstein, Univ Heart Ctr Luebeck, Dept Cardiol Angiol & Intens Care Med, Ratzeburger Allee 160, D-23538 Lubeck, Germany
[2] Partner Site Hamburg Kiel Luebeck, German Ctr Cardiovasc Res DZHK, Lubeck, Germany
[3] Klinikum Ludwigshafen, Med Klin B, Ludwigshafen, Germany
[4] Univ Leipzig, Dept Internal Med Cardiol, Heart Ctr Leipzig, Leipzig, Germany
关键词:
Multivessel coronary artery disease;
acute myocardial infarction;
cardiogenic shock;
reperfusion;
percutaneous coronary intervention;
REVASCULARIZATION;
PCI;
COUNTERPULSATION;
MANAGEMENT;
OUTCOMES;
D O I:
10.1177/2048872617719640
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background: Early revascularisation of the culprit lesion is the therapeutic cornerstone in cardiogenic shock complicating acute myocardial infarction. The optimal management of additional non-culprit lesions is unclear. This systematic review and meta-analysis aims to summarise current evidence on the comparison of immediate multivessel percutaneous coronary intervention (MV-PCI) or culprit lesion only PCI with possible staged revascularisation (C-PCI) in patients with cardiogenic shock complicating acute myocardial infarction. Methods: Medical literature databases were screened to identify analyses comparing MV-PCI with C-PCI in patients with cardiogenic shock complicating acute myocardial infarction and multivessel coronary artery disease. In absence of randomised trials, 10 cohort studies were included in the current meta-analysis. The primary outcome of short-term mortality was assessed at hospital discharge or 30 days after hospital admission. Secondary outcomes were long-term mortality as well as myocardial re-infarction, stroke, acute renal failure, and bleeding at short-term follow-up. Results: Of 6051 patients, 1194 (19.7%) received MV-PCI and 4857 (80.3%) C-PCI. Short-term mortality was 37.5% in patients undergoing MV-PCI compared with 28.8% in C-PCI patients (risk ratio 1.26, 95% confidence interval 1.12-1.41, p=0.001). Long-term mortality (p=0.77), myocardial re-infarction (p=0.77), stroke (p=0.12), acute renal failure (p=0.17) and bleeding (p=0.53) did not differ significantly between the two revascularisation groups. Conclusions: Results of this first meta-analysis on the interventional management of patients with cardiogenic shock complicating acute myocardial infarction and multivessel coronary artery disease do not support MV-PCI over C-PCI. However, possible treatment selection bias in the individual studies must be taken into account.
引用
收藏
页码:28 / 37
页数:10
相关论文
共 50 条